These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 24309867)
1. Metabolic syndrome among schizophrenia patients: study from a rural community of south India. Kumar CN; Thirthalli J; Suresha KK; Arunachala U; Gangadhar BN Asian J Psychiatr; 2013 Dec; 6(6):532-6. PubMed ID: 24309867 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of metabolic syndrome among inpatients with schizophrenia. Boke O; Aker S; Sarisoy G; Saricicek EB; Sahin AR Int J Psychiatry Med; 2008; 38(1):103-12. PubMed ID: 18624022 [TBL] [Abstract][Full Text] [Related]
3. Application of three-dimensional body scanner: observation of prevalence of metabolic syndrome. Lin JD; Chiou WK; Weng HF; Fang JT; Liu TH Clin Nutr; 2004 Dec; 23(6):1313-23. PubMed ID: 15556253 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of metabolic syndrome (METS) using IDF 2005 guidelines in a semi urban south Indian (Boloor Diabetes Study) population of Mangalore. Pemminati S; Prabha Adhikari MR; Pathak R; Pai MR J Assoc Physicians India; 2010 Nov; 58():674-7. PubMed ID: 21510460 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of metabolic syndrome in patients with schizophrenia in India. Grover S; Aggarwal M; Dutt A; Chakrabarti S; Avasthi A; Kulhara P; Somaiya M; Malhotra N; Chauhan N Psychiatry Res; 2012 Dec; 200(2-3):1035-7. PubMed ID: 22503355 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. McEvoy JP; Meyer JM; Goff DC; Nasrallah HA; Davis SM; Sullivan L; Meltzer HY; Hsiao J; Scott Stroup T; Lieberman JA Schizophr Res; 2005 Dec; 80(1):19-32. PubMed ID: 16137860 [TBL] [Abstract][Full Text] [Related]
7. [The metabolic syndrome and its components in participants of EUFEST]. Rabe-Jabłońska J; Pawełczyk T Psychiatr Pol; 2008; 42(1):73-85. PubMed ID: 18567405 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of metabolic syndrome in a rural community in Nigeria. Adegoke OA; Adedoyin RA; Balogun MO; Adebayo RA; Bisiriyu LA; Salawu AA Metab Syndr Relat Disord; 2010 Feb; 8(1):59-62. PubMed ID: 19929618 [TBL] [Abstract][Full Text] [Related]
9. Effect of metabolic syndrome on clinical outcomes of non-diabetic peritoneal dialysis patients in India. Prasad N; Sinha A; Gupta A; Sharma RK; Kaul A; Bhadauria D; Ranagswamy D Nephrology (Carlton); 2013 Oct; 18(10):657-64. PubMed ID: 23834643 [TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome among psychiatric inpatients with schizophrenia in Indonesia. Marthoenis M; Aichberger MC; Puteh I; Syahrial S; Schouler-Ocak M Asian J Psychiatr; 2015 Jun; 15():10-4. PubMed ID: 25910596 [TBL] [Abstract][Full Text] [Related]
11. The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome. Meyer JM; Nasrallah HA; McEvoy JP; Goff DC; Davis SM; Chakos M; Patel JK; Keefe RS; Stroup TS; Lieberman JA Schizophr Res; 2005 Dec; 80(1):9-18. PubMed ID: 16125372 [TBL] [Abstract][Full Text] [Related]
12. The prevalence of metabolic syndrome in patients with bipolar disorder. Garcia-Portilla MP; Saiz PA; Benabarre A; Sierra P; Perez J; Rodriguez A; Livianos L; Torres P; Bobes J J Affect Disord; 2008 Feb; 106(1-2):197-201. PubMed ID: 17631970 [TBL] [Abstract][Full Text] [Related]
13. [The prevalence of metabolic syndrome and related factors in patients with schizophrenia]. Cerit C; Ozten E; Yildiz M Turk Psikiyatri Derg; 2008; 19(2):124-32. PubMed ID: 18561044 [TBL] [Abstract][Full Text] [Related]
14. Epidemiological study of metabolic syndrome and risk of diabetes mellitus in a rural family medicine practice in Bacau County. Diaa A; Popa E; Bacusca A; Traian MG; Petrovanu R; Coman AE Rev Med Chir Soc Med Nat Iasi; 2014; 118(3):772-9. PubMed ID: 25341300 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over. Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989 [TBL] [Abstract][Full Text] [Related]
16. Components of the metabolic syndrome predictive of its development: a 6-year longitudinal study in Hong Kong Chinese. Cheung BM; Wat NM; Tam S; Thomas GN; Leung GM; Cheng CH; Woo J; Janus ED; Lau CP; Lam TH; Lam KS Clin Endocrinol (Oxf); 2008 May; 68(5):730-7. PubMed ID: 17980012 [TBL] [Abstract][Full Text] [Related]
17. Relationship between the prevalence of depressive symptoms and metabolic syndrome. Results of the SOPKARD Project. Gil K; Radziłłowicz P; Zdrojewski T; Pakalska-Korcala A; Chwojnicki K; Piwoński J; Ignaszewska-Wyrzykowska A; Załuga L; Mielczarek M; Landowski J; Wyrzykowski B Kardiol Pol; 2006 May; 64(5):464-9. PubMed ID: 16752328 [TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database. Sicras A; Rejas J; Navarro R; Serrat J; Blanca M Bipolar Disord; 2008 Jul; 10(5):607-16. PubMed ID: 18657245 [TBL] [Abstract][Full Text] [Related]
19. The metabolic syndrome in type 2 diabetic subjects in Gorgan, Iran. Marjani A; Mojerloo M J Pak Med Assoc; 2011 May; 61(5):458-61. PubMed ID: 22204179 [TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome among children and adolescents from Southern Italy: contribution from the Calabrian Sierras Community Study (CSCS). Martino F; Puddu PE; Pannarale G; Colantoni C; Zanoni C; Martino E; Barillà F Int J Cardiol; 2014 Dec; 177(2):455-60. PubMed ID: 25443246 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]